J-Oil Mills' menatto gets trademark approval in several countries

Published: 2-Dec-2022

The US, Japan, Europe, and Australia have authorised the trademark status.

Japan-based J-Oil Mills has announced menatto vitamin K2 (MK-7) has received trademark approval in several countries. The US, Japan, Europe, and Australia have authorised the trademark status.

"J-Oil Mills vitamin K2 (MK-7) is the original fermented vitamin K2 and has been incorporated into finished products across the globe for more than 20 years," noted Toshiro Sato, Director of the vitamin K2 study group in Japan and Senior Manager of R&D for J-Oil Mills. 

The company created the ingredient brand name menatto in 2021.

"Overall, vitamin K2 has gained much attention, and the marketing opportunities are now greater than ever. It has made its way into the mainstream of health-conscious consumers, joining vitamins A, C, E, and D, in many retail brands," said Sato.

Because menatto is the authentic Japanese, fully traceable, original fermented Vitamin K2, this is why we created the menatto tagline, The Japanese Original

“Because menatto is the authentic Japanese, fully traceable, original fermented Vitamin K2, this is why we created the menatto tagline, The Japanese Original," added Hikaru Asari, Section Manager of Fine Materials Business, Specialty Food Products Unit for Tokyo. 

menatto is manufactured in a GMP and ISO 22000-certified facility in Japan and has achieved self-affirmed GRAS and novel food status, allowing for its use in foods and beverages, as well as conventional tablets, capsules, gummies, and chews. menatto is available as vitamin K2 (MK-7) Oil 1500 and as vitamin K2 (MK-7) Powder 1000/2000.

menatto is made from a bacterial strain isolated from the traditional fermented Japanese food “Natto.” The company’s ingredient has been researched in Japan, by some of the country's most respected scientists.

In addition, menatto K2 (MK-7) M1500 and P2000 have been evaluated by a third-party technical administrator and meet the Non-GMO Project’s Standard for GMO avoidance.

”The ingredient is backed by 10 well-controlled original human clinical trials published in peer-reviewed scientific journals, and includes a suite of intellectual property, consisting of three international product usage patents and a Japanese process patent and trademarks," said Asari. Several condition-specific uses are supported by original research including bone health, heart health, joint health, hair/skin/nails (beauty), and for healthy blood coagulation. 

Trending Articles

You may also like